Asia-Pacific Plasma Therapy Market to be worth $214 Million by 2030
Meticulous
Research®, a leading global market
research company, published a research report titled,
‘Asia-Pacific Plasma Therapy Market, By Type
(Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics,
Dermatology, Cosmetology, Rheumatology, Ophthalmology, Stomatology), End User
(Hospitals & Clinics, Research Institutes) - Forecast to 2030’.
According to this latest publication from
Meticulous Research®, the
Asia-Pacific Plasma Therapy Market is expected to reach $214 million by 2030 at
a CAGR of 13.4% from 2023 to 2030. The growth of the Asia-Pacific plasma
therapy market is attributed to the significant rise in healthcare expenditure,
the growing geriatric population, and the significant number of accidents in
the region. In addition, the conferences promoting the use of platelet-rich
Plasma (PRP) and research activities with PRP therapy are further expected to
drive the growth of the market in Asia-Pacific. However, the stringent
regulatory framework for PRP use is the major challenge in this market.
Increasing applications of PRP treatments and advancements in healthcare
infrastructure in Asia-Pacific countries provide market growth opportunities.
Download
Free PDF Sample Copy of the Report (with COVID-19 Impact Analysis): https://www.meticulousresearch.com/download-sample-report/cp_id=5556
Scope of the
Report:
Asia-Pacific
Plasma Therapy Market Assessment, by Type
·
Pure PRP
·
Leukocyte-rich PRP
·
Pure Platelet-rich Fibrin
·
Leukocyte and Platelet-rich Fibrin (L-PRF)
Asia-Pacific
Plasma Therapy Market Assessment, by Application
·
Orthopaedics & Traumatology
·
Rheumatology
·
Dermatology & Cosmetology
·
Ophthalmology
·
Stomatology & Odontology
·
OtherApplications
(Note: Other Applications include Sexual Health, Infertility Support,
Migraine, and Neurological Issues.)
Asia-Pacific
Plasma Therapy Market Assessment, by End User
·
Hospitals & Clinics
·
Research Institutes
Asia-Pacific
Plasma Therapy Market Assessment, by Country
·
China
·
Japan
·
India
·
South Korea
·
Australia
·
Singapore
·
Rest of Asia-Pacific
To
Gain More Insights into the Market with a Detailed Table of Content and
Figures, Click Here: https://www.meticulousresearch.com/product/asia-pacific-plasma-therapy-market-5556
Key
Players
The key players operating in the Asia-Pacific
plasma therapy market are Arthrex, Inc. (U.S.) DePuy Synthesis, Inc. (Johnson
& Johnson) (U.S.), Global Stem Cells Group, Inc.(U.S.), Terumo Corporation
(Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.) Zimmer Biomet
Holdings, Inc. (U.S.), Exactech Inc. (U.S.), Beijing Manson Technology Co.,
Ltd. (China), Alocuro (Australia), Takeda Pharmaceutical Company Limited
(Japan), Grifols, S.A.(Spain), Octapharma AG (Switzerland), and CSL Limited
(Australia).
Asia-Pacific
Plasma Therapy Market: Future Outlook
The Asia-Pacific plasma therapy market is
segmented by type (Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin, and
Leukocyte and Platelet-rich Fibrin), application (Orthopedics &
Traumatology, Rheumatology, Dermatology & Cosmetology, Ophthalmology, Stomatology
& Odontology, and Other Applications), end user (Hospitals & Clinics
& Research Institutes) and country. The study also evaluates industry
competitors and analyzes their market share at the country level.
Among all
types studied in this report, in
2023, the pure PRP segment is expected to have the largest market share. Pure
PRP is one of the preferred methods as it is a point-of-care therapy in the
place of surgery or other invasive methods, primarily contributing to the
largest share of the segment. Additionally, increasing application of pure PRP,
such as treating torn tendons, tendinitis, muscle injuries, arthritis-related
pain, joint injuries, hair loss, and others, contributes to the segment's
largest share.
Request Customization Here:
https://www.meticulousresearch.com/request-customization/cp_id=5556
Among all
applications studied in this report, the
dermatology & cosmetology segment is expected to register the highest CAGR
over the forecast period. The high incidence of skin and hair-related
conditions, the increased popularity worldwide concerning looking good, and
lucrative facial features are the major driving factors for the segment.
Additionally, the high incidence of dermatological problems and the advantages
of PRP therapy in dermatology is expected to drive the segmental growth of the
market.
Among all
end users studied in this report, in
2023, the hospitals & clinics segment is expected to have the largest
market share. Hospitals and clinics use platelet-rich plasma (PRP) therapy for
pain management, regenerative medicines, joint & bone surgeries, cosmetic
enhancements, hair growth, and sports injuries. PRP treatments are mostly
applied to manage accidents and trauma, infectious diseases, orthopedic
treatments, cosmetics, dermatology, and hair growth & transplant,
contributing to the largest segment share.
Geographic
Review
This research report analyzes major countries
and comprehensively analyzes China, Japan, India, South Korea, Australia,
Singapore, and the Rest of Asia-Pacific. In 2023, Japan is expected to account
for the largest share of the Asia-Pacific plasma therapy market. The country's
large market share is attributed to the growing awareness about PRP therapy,
the rising number of road accidents, the growing preference for cosmetic
procedures, and increasing infertility. For instance, many people in the
country are affected by infertility. The World Bank reported that the country's
fertility rate in 2019 was 1.4 births per woman, which declined to 1.3 births
per woman in 2021. Physicians involved in in-vitro fertilization (IVF) use PRP to
promote endometrial growth and improve pregnancy chances. The decline in the
fertility rate and the adoption of PRP in infertility is expected to drive the
market demand in the country.
You
can Buy Report from Here: https://www.meticulousresearch.com/Checkout/57765948
Key
questions answered in the report-
· Which are the high-growth market segments in terms of type,
application, end user, and country?
· What was the historical market for plasma therapy market in
Asia-Pacific?
· What are the market forecasts and estimates for 2023–2030?
· What are the major drivers, restraints, challenges, and
opportunities in the Asia-Pacific plasma therapy market?
· Who are the major players in the Asia-Pacific plasma therapy
market?
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment